LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book ...

A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe form of age-related macular degeneration (AMD), a common eye disease and ...

A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The groundbreaking device, called PRIMA, has partially restored vision in people ...

A wireless brain implant designed to restore artificial vision has been successfully implanted in ...

Please provide your email address to receive an email when new articles are posted on . Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal ...

Good baseline visual acuity retained in three-fourths of patients at 36 weeks with OTX-TKI ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Electronic retinal implants like the PRIMA system can partially restore central vision in ...

A hybrid retinal implant using stem-cell-derived neurons and microelectrodes lowers activation thresholds and improves signal precision, offering a more natural interface for high-resolution vision ...

This week, researchers reported that malaria influenced population distribution in Africa thousands of years ago.

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved a dexamethasone 0.7-mg intravitreal implant (Ozurdex, Allergan, Inc) for the treatment of macular edema after branch ...